Authors:
BELL IM
ERB JM
FREIDINGER RM
GALLICCHIO SN
GUARE JP
GUIDOTTI MT
HALPIN RA
HOBBS DW
HOMNICK CF
KUO MS
LIS EV
MATHRE DJ
MICHELSON SR
PAWLUCZYK JM
PETTIBONE DJ
REISS DR
VICKERS S
WILLIAMS PD
WOYDEN CJ
Citation: Im. Bell et al., DEVELOPMENT OF ORALLY-ACTIVE OXYTOCIN ANTAGONISTS - STUDIES ON DIN-3-YLMETHYL)PIPERIDIN-4-YLOXY]-2-METHOXYBENZOYL IPERIDIN-4-YL)-1,4-DIHYDROBENZ[D][1,3]OXAZIN-2-ONE (L-372,662) AND RELATED PYRIDINES, Journal of medicinal chemistry, 41(12), 1998, pp. 2146-2163
Authors:
WILLIAMS PD
CLINESCHMIDT BV
ERB JM
FREIDINGER RM
GUIDOTTI MT
LIS EV
PAWLUCZYK JM
PETTIBONE DJ
REISS DR
VEBER DF
WOYDEN CJ
Citation: Pd. Williams et al., ENZOYL]PIPERIDIN-4-YL)-4H-3,1-BENZOXAZIN-2(1H)-ONE (L-371,257) - A NEW, ORALLY BIOAVAILABLE, NONPEPTIDE OXYTOCIN ANTAGONIST, Journal of medicinal chemistry, 38(23), 1995, pp. 4634-4636
Authors:
PETTIBONE DJ
CLINESCHMIDT BV
GUIDOTTI MT
LIS EV
REISS DR
WOYDEN CJ
BOCK MG
EVANS BE
FREIDINGER RM
HOBBS DW
VEBER DF
WILLIAMS PD
CHIU SHL
THOMPSON KL
SCHORN TW
SIEGL PKS
KAUFMAN MJ
CUKIERSKI MA
HALUSKA GJ
COOK MJ
NOVY MJ
Citation: Dj. Pettibone et al., L-368,899, A POTENT ORALLY-ACTIVE OXYTOCIN ANTAGONIST FOR POTENTIAL USE IN PRETERM LABOR, Drug development research, 30(3), 1993, pp. 129-142